Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 1

Research Article

Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism

Table 1

Body weight (g) changes after oral gavage for 4 weeks of preischemia daily doses of Vehicle or SAC treatment.

Time/groupVehicleSAC 0.18 mgSAC 0.018 mgSAC 0.0018 mg

Baseline220.2 ± 18.1217.0 ± 18.2221.8 ± 16.9224.0 ± 18.1
Week 1258.2 ± 16.0257.3 ± 14.5262.2 ± 15.8269.5 ± 18.2
Week 2282.2 ± 13.8280.0 ± 8.3304.5 ± 14.7292.0 ± 12.1
Week 3324.0 ± 12.3310.7 ± 6.7325.7 ± 9.1328.2 ± 8.2
Week 4321.0 ± 9.5322.3 ± 8.7323.3 ± 12.5330.7 ± 17.7

Body weights (BWs) were measured at the baseline (0 week) or 1/2/3/4 weeks after oral gavage of preischemia administration of daily doses of vehicle or SAC (0.18, 0.018 or 0.0018 mg) treatment. The results are recorded without following ischemia and represented as mean ± S.E.M. (n = 6∼11). SAC, S-allyl L-cysteine.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.